← Back to Search

Regular vs Clear Liquid Diet for Pancreatitis

N/A
Recruiting
Led By James Buxbaum, MD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Presentation with acute pancreatitis as defined by two of three criterion per the Revised Atlanta Criteria guidelines: (a) Amylase or lipase > 3x the upper limit of normal, b) Classical abdominal pain, c) Ultrasound or computed tomography of unequivocal pancreatitis. Such radiographic findings include swelling, edema, or heterogeneity of the gland or peripancreatic fluid or stranding
18 years of age or older
Must not have
Etiologies of hypertriglyceridemia, trauma and autoimmune pancreatitis will be excluded
Surgical intervention for infected pancreatic necrosis or pancreatic hemorrhage
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from date of randomization until the date of discharge at 24, 48, 72 hours and at discharge, assessed up to 24 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether a full calorie diet or a clear liquid diet is better for people with mild to moderate acute pancreatitis when it comes to length of hospital stay.

Who is the study for?
This trial is for adults over 18 with mild to moderate acute pancreatitis, confirmed by specific diagnostic criteria. It's not for pregnant or breastfeeding women, those unable to consent, transferred from other hospitals, with chronic/severe pancreatitis, certain etiologies like hypertriglyceridemia or trauma, and those who can't eat orally due to other medical issues.
What is being tested?
The study compares the effects of a full calorie regular diet (RD) versus a clear liquid diet (CLD) on hospital stay length in patients with mild to moderate acute pancreatitis. The main goal is seeing if one diet type helps patients leave the hospital sooner.
What are the potential side effects?
Potential side effects are not specified but may include digestive discomfort or nutritional deficiencies depending on individual tolerance and response to either the regular or clear liquid diets prescribed during treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have acute pancreatitis according to the Atlanta Criteria.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My high triglycerides are not due to trauma, autoimmune pancreatitis, or other causes.
Select...
I had surgery for infected pancreatic tissue or bleeding.
Select...
I am under 18 years old.
Select...
I cannot or do not want to give permission for treatment.
Select...
I do not have severe pancreatitis according to the Revised Atlanta Criteria.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from date of randomization until the date of discharge at 24, 48, 72 hours and at discharge, assessed up to 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and from date of randomization until the date of discharge at 24, 48, 72 hours and at discharge, assessed up to 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Length of Hospitalization Stay
Secondary study objectives
30 day hospital readmission
Calorie and fat intake
Change in Pancreatic Activity Scoring System Score
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Regular DietActive Control1 Intervention
Patient randomized to regular diet will begin with a regular diet.
Group II: Clear Liquid DietActive Control1 Intervention
Patient randomized to clear liquid diet will begin with a clear liquid diet.

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor
944 Previous Clinical Trials
1,604,495 Total Patients Enrolled
3 Trials studying Acute Pancreatitis
1,798 Patients Enrolled for Acute Pancreatitis
James Buxbaum, MDPrincipal InvestigatorPrincipal Investigator
6 Previous Clinical Trials
960 Total Patients Enrolled

Media Library

Clear Liquid Diet Clinical Trial Eligibility Overview. Trial Name: NCT04932785 — N/A
Acute Pancreatitis Research Study Groups: Regular Diet, Clear Liquid Diet
Acute Pancreatitis Clinical Trial 2023: Clear Liquid Diet Highlights & Side Effects. Trial Name: NCT04932785 — N/A
Clear Liquid Diet 2023 Treatment Timeline for Medical Study. Trial Name: NCT04932785 — N/A
~35 spots leftby Nov 2025